B De la Parra - JoVE Visualize

Showing results (1-10 of 10) with videos related to

Pageof 1

Sort By:

Allergy|August 1, 1986

IgE synthesis in vitro: attempt to isolate stimulating factorsB De la Parra, N Vulliet, J P Girard

Immunology Letters|January 1, 1985

In vitro production of IgE in humans: kinetic studies and analysis of serum enhancing and inhibitory factorsB de la Parra, L Wilson, S Zawodnik, et al.

Xenotransplantation|July 27, 2001

Effect in vitro and in vivo of a rat anti-CD2 monoclonal antibody (LO-CD2b) on pig-to-baboon xenogeneic cellular (T and natural killer cells) immune responseJ P Dehoux, B de la Parra, D Latinne, et al.

Xenotransplantation|August 29, 2000

Human and non-human primate anti-galactosyl response after injection of rat monoclonal antibody bearing galactosyl epitopesJ P Dehoux, B de la Parra, D Latinne, et al.

Bone Marrow Transplantation|October 1, 1995

Prophylaxis of graft-versus-host disease in identical sibling donor bone marrow transplant by anti-IL-2 receptor monoclonal antibody LO-Tact-1A Ferrant, D Latinne, H Bazin, et al.

Transplantation|December 28, 1999

Differential effects of injections of anti-mu and anti-delta monoclonal antibodies on B-cell populations in adult mice: regulation of xenoreactive natural antibody-producing cellsA A Chentoufi, Y Nizet, X Havaux, et al.

International Immunology|July 1, 1996

An anti-CD2 mAb induces immunosuppression and hyporesponsiveness of CD2+ human T cells in vitroD Latinne, B De La Parra, Y Nizet, et al.

Transplantation|July 26, 2000

Effects on human and nonhuman primate immune response of a new rat anti-CD2 monoclonal antibodyJ P Dehoux, S Talpe, N Dewolf, et al.

Transplantation|May 8, 2000

The experimental (in vitro) and clinical (in vivo) immunosuppressive effects of a rat IgG2b anti-human CD2 mAb, LO-CD2a/BTI-322Y Nizet, A A Chentoufi, B de la Parra, et al.

Transplantation|May 15, 1996

Prophylactic immunosuppression with anti-interleukin-2 receptor monoclonal antibody LO-Tact-1 versus OKT3 in liver allografting. A two-year follow-up studyR Reding, A Feyaerts, H Vraux, et al.

Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:

Pageof 1

Allergy|August 1, 1986

IgE synthesis in vitro: attempt to isolate stimulating factorsB De la Parra, N Vulliet, J P Girard

Immunology Letters|January 1, 1985

In vitro production of IgE in humans: kinetic studies and analysis of serum enhancing and inhibitory factorsB de la Parra, L Wilson, S Zawodnik, et al.

Xenotransplantation|July 27, 2001

Effect in vitro and in vivo of a rat anti-CD2 monoclonal antibody (LO-CD2b) on pig-to-baboon xenogeneic cellular (T and natural killer cells) immune responseJ P Dehoux, B de la Parra, D Latinne, et al.

Xenotransplantation|August 29, 2000

Human and non-human primate anti-galactosyl response after injection of rat monoclonal antibody bearing galactosyl epitopesJ P Dehoux, B de la Parra, D Latinne, et al.

Bone Marrow Transplantation|October 1, 1995

Prophylaxis of graft-versus-host disease in identical sibling donor bone marrow transplant by anti-IL-2 receptor monoclonal antibody LO-Tact-1A Ferrant, D Latinne, H Bazin, et al.

Transplantation|December 28, 1999

Differential effects of injections of anti-mu and anti-delta monoclonal antibodies on B-cell populations in adult mice: regulation of xenoreactive natural antibody-producing cellsA A Chentoufi, Y Nizet, X Havaux, et al.

International Immunology|July 1, 1996

An anti-CD2 mAb induces immunosuppression and hyporesponsiveness of CD2+ human T cells in vitroD Latinne, B De La Parra, Y Nizet, et al.

Transplantation|July 26, 2000

Effects on human and nonhuman primate immune response of a new rat anti-CD2 monoclonal antibodyJ P Dehoux, S Talpe, N Dewolf, et al.

Transplantation|May 8, 2000

The experimental (in vitro) and clinical (in vivo) immunosuppressive effects of a rat IgG2b anti-human CD2 mAb, LO-CD2a/BTI-322Y Nizet, A A Chentoufi, B de la Parra, et al.

Transplantation|May 15, 1996

Prophylactic immunosuppression with anti-interleukin-2 receptor monoclonal antibody LO-Tact-1 versus OKT3 in liver allografting. A two-year follow-up studyR Reding, A Feyaerts, H Vraux, et al.

Pageof 1